| Literature DB >> 19249506 |
N Arichi1, H Kishikawa, Y Mitsui, T Kato, K Nishimura, R Tachikawa, K Tomii, H Shiina, M Igawa, Y Ichikawa.
Abstract
Pneumocystis pneumonia (PCP), a life-threatening opportunistic infection occurring in immunocompromised hosts, developed in 10 patients in the past 35 years at our hospital. Among the 7 outpatients and 3 inpatients, 9 cases clustered within 7 months. The mean time was 32.1 +/- 27.5 months between transplantation and PCP diagnosis. The mortality rate was 33.3%. The patients developing PCP were older at transplantation (46.9 +/- 11.8 vs 34.0 +/- 11.1 years; P = .003) and had a longer pretransplantation dialysis period (146.3 +/- 120.0 vs 51.3 +/- 66.6 months; P < .0001). Multivariate analysis showed that age at transplantation and the use of mycophenolate mofetil (MMF) were risk factors for development of PCP. Despite prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) during the first 3 to 6 months after transplantation, the time period that showed the highest incidence rate of PCP, the disease may occur at later intervals.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19249506 DOI： 10.1016/j.transproceed.2008.10.027
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066